Tearsheet
Investment Highlights Market Valuation Price Chart Return vs. Risk About EMPG Interactive Breakdown Better Bets vs. EMPG Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Empro (EMPG)

Market Price (10/31/2025): $17.55 | Market Cap: $-
Sector: Health Care | Industry: Health Care Distributors

Empro (EMPG)

Market Price (10/31/2025): $17.55
Market Cap: $-
Sector: Health Care
Industry: Health Care Distributors

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

null
null

Market Valuation & Key Metrics

null

EMPG Stock

null
Factor Drivers of Stock Movement
null

null
null

null
null

null

Return vs. Risk

Price Returns Compared

 202020212022202320242025Total [1]
Returns
EMPG Return------0%
Peers Return11%20%27%16%9%30%177%
S&P 500 Return16%27%-19%24%23%16%110%

Monthly Win Rates [3]
EMPG Win Rate------ 
Peers Win Rate40%45%50%50%45%53% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
EMPG Max Drawdown------ 
Peers Max Drawdown-17%-5%-4%-11%-4%-2% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: COR, CAH, EMPG, MCK, HSIC.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/30/2025 (YTD)

How Low Can It Go

EMPG has limited trading history. Below is the Health Care sector ETF (XLV) in its place.

Unique KeyEventXLVS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-16.1%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven19.1%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven599 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-28.8%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven40.4%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven116 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-15.8%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven18.8%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven326 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-40.6%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven68.3%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven1100 days1480 days

Compare to


In The Past

SPDR Select Sector Fund's stock fell -16.1% during the 2022 Inflation Shock from a high on 4/8/2022. A -16.1% loss requires a 19.1% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Empro (EMPG)

Trade Ideas

Select past ideas related to EMPG. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ADMA_9302025_Dip_Buyer_ValueBuy09302025ADMAADMA BiologicsDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		5.9%5.9%-4.6%
REGN_9302025_Dip_Buyer_ValueBuy09302025REGNRegeneron PharmaceuticalsDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		16.1%16.1%-0.8%
HAE_9262025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG09262025HAEHaemoneticsDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap		2.6%2.6%-0.1%
WAT_9192025_Monopoly_xInd_xCD_Getting_Cheaper09192025WATWatersMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		14.2%14.2%-4.3%
ISRG_9052025_Monopoly_xInd_xCD_Getting_Cheaper09052025ISRGIntuitive SurgicalMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		15.2%15.2%-8.0%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ADMA_9302025_Dip_Buyer_ValueBuy09302025ADMAADMA BiologicsDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		5.9%5.9%-4.6%
REGN_9302025_Dip_Buyer_ValueBuy09302025REGNRegeneron PharmaceuticalsDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		16.1%16.1%-0.8%
HAE_9262025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG09262025HAEHaemoneticsDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap		2.6%2.6%-0.1%
WAT_9192025_Monopoly_xInd_xCD_Getting_Cheaper09192025WATWatersMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		14.2%14.2%-4.3%
ISRG_9052025_Monopoly_xInd_xCD_Getting_Cheaper09052025ISRGIntuitive SurgicalMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		15.2%15.2%-8.0%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PRAXPraxis Precision Medicines279.1%161.2%
2INBXInhibrx Biosciences131.0%409.8%
3PUMPProPetro99.6%16.2%
4DYNDyne Therapeutics88.4%-0.0%
5VICRVicor85.4%89.2%
6CELCCelcuity74.6%503.2%
7GLUEMonte Rosa Therapeutics73.5%87.5%
8NVTSNavitas Semiconductor72.1%251.8%
9LUMNLumen Technologies70.3%94.7%
10BALYBallys63.4%4.1%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical-62.9%5106.3%
2LRNStride-53.8%-35.8%
3FMCFMC-51.0%-66.6%
4FIFiserv-48.3%-68.3%
5NFENew Fortress Energy-43.6%-91.9%
6VGVenture Global-41.7% 
7OGNOrganon-40.2%-55.0%
8VRNSVaronis Systems-39.5%-21.2%
9ITGRInteger-38.5%-52.2%
10LENZLENZ Therapeutics-37.9%5.5%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Empro

Financials

EMPGCORCAHMCKHSICMedian
NameEmpro Cencora Cardinal.McKesson Henry Sc. 
Mkt Price-341.21189.84825.5362.90265.52
Mkt Cap-66.145.2103.17.755.7
Rev LTM-316,654222,578377,59512,773269,616
Op Inc LTM-3,7132,3224,7487713,017
FCF LTM-1,1421,8505,6663341,496
FCF 3Y Avg-2,5882,4884,4634362,538
CFO LTM-1,7422,3976,5475122,070
CFO 3Y Avg-3,1013,0015,1946193,051

Growth & Margins

EMPGCORCAHMCKHSICMedian
NameEmpro Cencora Cardinal.McKesson Henry Sc. 
Rev Chg LTM-11.6%-1.9%20.3%2.3%6.9%
Rev Chg 3Y Avg-10.3%7.3%12.2%0.2%8.8%
Rev Chg Q-8.7%0.5%23.4%3.3%6.0%
QoQ Delta Rev Chg LTM-2.1%0.1%5.2%0.8%1.4%
Op Mgn LTM-1.2%1.0%1.3%6.0%1.2%
Op Mgn 3Y Avg-1.1%1.0%1.4%5.8%1.3%
QoQ Delta Op Mgn LTM-0.0%0.0%-0.1%-0.0%-0.0%
CFO/Rev LTM-0.6%1.1%1.7%4.0%1.4%
CFO/Rev 3Y Avg-1.1%1.4%1.6%4.9%1.5%
FCF/Rev LTM-0.4%0.8%1.5%2.6%1.2%
FCF/Rev 3Y Avg-0.9%1.1%1.4%3.5%1.3%

Valuation

EMPGCORCAHMCKHSICMedian
NameEmpro Cencora Cardinal.McKesson Henry Sc. 
Mkt Cap-66.145.2103.17.755.7
P/S-0.20.20.30.60.2
P/EBIT-22.519.522.611.621.0
P/E-34.928.932.619.730.8
P/CFO-38.018.815.715.017.3
Total Yield-3.5%4.5%3.4%5.1%4.0%
Dividend Yield-0.7%1.1%0.3%0.0%0.5%
FCF Yield 3Y Avg-5.9%9.3%6.1%4.8%6.0%
D/E-0.10.20.10.40.2
Net D/E-0.10.10.10.40.1

Returns

EMPGCORCAHMCKHSICMedian
NameEmpro Cencora Cardinal.McKesson Henry Sc. 
1M Rtn-9.2%20.9%6.9%-5.2%8.0%
3M Rtn-19.5%22.7%19.2%-7.0%19.3%
6M Rtn-17.9%31.3%17.1%-2.4%17.5%
12M Rtn-49.9%78.5%66.1%-11.0%58.0%
3Y Rtn-124.1%164.9%115.0%-8.1%119.5%
1M Excs Rtn-7.8%18.5%6.2%-5.8%7.0%
3M Excs Rtn-9.2%12.7%8.9%-16.8%9.0%
6M Excs Rtn--3.8%9.5%-4.7%-24.2%-4.2%
12M Excs Rtn-30.2%56.5%45.8%-28.7%38.0%
3Y Excs Rtn-53.9%96.0%42.1%-86.5%48.0%

Financials

$ Mil | FY: 12/31
Period End
Filing Date
Key Financials Quarterly
Total Revenue
Ebitda
Operating Income
Net Income
EPS
Key Financials TTM
Total Revenue TTM
Ebitda TTM
Operating Income TTM
Net Income TTM
Growth Rates Quarterly
Total Revenue Growth
EBITDA Growth
Operating Income Growth
Net Income Growth
Margins Quarterly
EBITDA Margin
Operating Income Margin
Net Income Margin
Cash & Debt
Total Cash
Total Debt
Net Debt / (Cash)
Cash Flows Quarterly
FCF from Operations
Cash Flows TTM
FCF from Operations TTM
Returns to Shareholders Quarterly
Dividends
Share Repurchases
Return on Invested Capital (ROIC) Quarterly
ROIC
Return on Invested Capital (ROIC) TTM
ROIC TTM

Short Interest

Short Interest: As Of Date10152025
Short Interest: Shares Quantity47,142
Short Interest: % Change Since 9302025-45.0%
Average Daily Volume216,109
Days-to-Cover Short Interest1

SEC Filings

Expand for More

Report DateFiling DateFiling
123120243312025F-1/A 12/31/2024
630202410162024F-1/A 6/30/2024
123120239162024F-1 12/31/2023
1231202212292023DRS 12/31/2022

Insider Activity

Expand for More

 

Industry Resources

External Quote Links


Prefer one of these to Trefis? Tell us why.